SNDX
#2106
Syndax Pharmaceuticals, Inc. - Common Stock
19.5 4 USD
-0.03%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-3.08%
Monthly Change
+1.93%
6 month change
-9.58%
Year Change
+18.42%
Previous Close
20.1 6
Open
19.5 4
Low
19.5 4
High
19.5 4
Volume
98
Financials
- Market Capitalization 1.74 B
- Employee 298
- Founded 2005
- CEO N/A
- Website www.syndax.com
- Headquarter Delaware, United States
- FIGI BBG000R33JY1
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-6.39
Price to sales ratio
10.56
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2084 |  FTRE Fortrea Holdings Inc. - Common Stock | 18.81 USD | -0.27% | +3.69% | -8.06% | +95.12% | 1.79 B USD | ||
| 2091 |  RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.34 USD | -2.91% | -2.05% | +11.71% | -27.23% | 1.79 B USD | ||
| 2110 |  GHRS GH Research PLC - Ordinary Shares | 27.94 USD | -2.48% | -0.92% | -0.21% | +97.32% | 1.73 B USD | ||
| 2122 |  AAPG Ascentage Pharma Group International - American Depository Shar | 18.28 USD | -2.40% | +8.62% | -0.81% | -26.88% | 1.71 B USD |
Frequently asked questions about Syndax Pharmaceuticals, Inc.
What is the Syndax Pharmaceuticals, Inc. stock price today?
The current price of Syndax Pharmaceuticals, Inc. (SNDX) is 19.54. Over the past 24 hours, the stock has changed by -3.08%. Follow the SNDX chart for real-time price dynamics.
What is the stock ticker of Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. trades under the ticker SNDX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Syndax Pharmaceuticals, Inc. stock going up?
SNDX has changed by -0.76% over the last week, +1.93% over the last month, and +18.42% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. currently has a market capitalization of 1.74 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Syndax Pharmaceuticals, Inc. earnings last quarter?
Last quarter, Syndax Pharmaceuticals, Inc. reported earnings of -0.55 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Syndax Pharmaceuticals, Inc. revenue for the last quarter?
Syndax Pharmaceuticals, Inc. reported quarterly revenue of 72.79 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Syndax Pharmaceuticals, Inc. net income for the last quarter?
Syndax Pharmaceuticals, Inc. reported net income of -49.36 M for the last quarter. The previous quarter showed -42.67 M, which means net income changed by -15.68%.
How many employees does Syndax Pharmaceuticals, Inc. have?
As of the latest available data, Syndax Pharmaceuticals, Inc. has 298 employees. Workforce size can provide additional context about the company's scale and operations.
What is Syndax Pharmaceuticals, Inc. EBITDA?
Syndax Pharmaceuticals, Inc. EBITDA is -35.4 M, and its EBITDA margin is -48.63%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Syndax Pharmaceuticals, Inc. stock?
You can buy Syndax Pharmaceuticals, Inc. (SNDX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Syndax Pharmaceuticals, Inc. stock?
Investing in Syndax Pharmaceuticals, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SNDX chart and related analysis on metatrader.com as part of your research.